Assignee
ONCOBIX CO LTD
KR·2 granted patents·3 pending applications·1 citations·filing 2018–2022
Top patents by PatentIndex Score
5 records- 0165US11248003B2Pyrimidine derivative having effect of inhibiting cancer cell growth and pharmaceutical composition containing sameONCOBIX CO LTD·Filed 2018·Granted Feb 15, 2022·1 cites·15 claims
- 0254US2024166663A1Novel pyrimidine derivative showing inhibition effect on growth of cancer cellsONCOBIX CO LTD·Filed 2022·Application pending·0 cites
- 0343US2022227781A1Pyrimidine derivative inhibiting growth of cancer cell and medicinal use thereofONCOBIX CO LTD·Filed 2020·Application pending·0 cites
- 0441US12421221B2Heterocyclic-substituted pyrimidine derivative exhibiting cancer cell growth inhibitory effect, and pharmaceutical composition containing sameONCOBIX CO LTD·Filed 2020·Granted Sep 23, 2025·0 cites·8 claims
- 0540US2023114177A1Novel deuterium-substituted pyrimidine derivative and pharmaceutical composition comprising sameONCOBIX CO LTD·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →